N24044
yx93d09.s1 Soares melanocyte 2NbHM Homo sapiens cDNA clone IMAGE:269297 3' similar to SP:RS9_RAT P29314 40S RIBOSOMAL PROTEIN, mRNA sequence.
467
mRNA
Homo sapiens
DM760738
JP 2014079248-A/24044: NEISSERIAL ANTIGENIC PEPTIDES.
12
PRT
Neisseria
MD756286
JP 2019507579-A/24044: MATERIALS AND METHODS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY.
20
DNA
synthetic construct
HW189072
JP 2013102767-A/23996: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
DD550647
JP 2004508801-A/24044: NEISSERIAL ANTIGENIC PEPTIDES.
12
PRT
Neisseria
DM798502
JP 2014068652-A/24044: NEISSERIAL ANTIGENIC PEPTIDES.
12
PRT
Neisseria
OG508230
JP 2018534252-A/24044: PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF.
37
PRT
synthetic construct
DJ153424
JP 2007228956-A/24042: Method for identification of useful proteins derived from brewery yeast.
25
DNA
Saccharomyces pastorianus
FU798525
JP 2009528046-A/24042: Method for identifying useful proteins of brewery yeast.
25
DNA
Saccharomyces pastorianus
LX121660
JP 2017506877-A/24042: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes.
16
DNA
synthetic construct
OG753563
JP 2021120380-A/24044: CANCER NEOEPITOPES.
9
PRT
Homo sapiens
HV880585
JP 2010507387-A/23996: Novel siRNAs and Methods of Use Thereof.
21
RNA
synthetic construct
LV569866
JP 2017029159-A/24044: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
DL614646
JP 2011092200-A/24044: NEISSERIAL ANTIGENIC PEPTIDES.
12
PRT
Neisseria
MC776154
JP 2018525446-A/24044: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
30
PRT
synthetic construct
DL033058
JP 2005512499-A/24044: Diagnosis of existing illnesses or that praedisposition for determined illnesses.
505
DNA
synthetic construct
HZ528825
JP 2016501039-A/24044: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
PA394767
JP 2021533803-A/23850: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE.
26
DNA
Homo sapiens
OG660430
JP 2021500321-A/24044: METHODS AND COMPOSITIONS FOR INHIBITING ADAM10 BIOLOGICAL ACTIVITIES.
189
PRT
synthetic construct
LF683265
JP 2016521556-A/24044: COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION.
15
DNA
Homo sapiens
LF831200
JP 2016528161-A/24033: COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS.
18
DNA
synthetic construct
PA339692
JP 2021522188-A/24044: Compositions and Methods for Multiplexed Tumor Vaccination with Endogenous Gene Activation.
20
DNA
synthetic construct
PA528528
JP 2022502046-A/11310: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY.
21
DNA
synthetic construct
MC552543
JP 2019525738-A/24043: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES.
5
PRT
synthetic construct
MD270177
JP 2020517247-A/24044: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof.
20
DNA
synthetic construct
MC165888
JP 2019500349-A/24044: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES.
18
RNA
synthetic construct
HW859268
JP 2015051004-A/23996: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
DJ527844
JP 2010517930-A/24044: Method of constructing and screening libraries of peptide structures.
12
PRT
synthetic construct
DL905788
JP 2014205669-A/24044: Method of constructing and screening libraries of peptide structures.
12
PRT
synthetic construct
MB764238
JP 2018535655-A/28135: ASGR INHIBITORS.
9
PRT
synthetic construct